Clinical Trial Update: TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (TRINITY-US) [NA]

View source ↗

Summary

This update covers the TRINITY-US trial evaluating the LuX-Valve Plus System for tricuspid regurgitation. The study is currently listed as Active Not Recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Lux-Valve Plus System

Snippet

Sponsor: Jenscare Innovation Inc. | Conditions: Tricuspid Regurgitation (TR) | NA | Status: ACTIVE_NOT_RECRUITING